Álvaro Morales-Molina (Alvaro Morales-Molina)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Mesenchymal Stem Cells

Toll Like Receptor

Immune Response

Top Venues

Cancer research communications

Cancer immunology, immunotherapy : CII

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Álvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Stefano Gambera, Teresa Cejalvo, Belén de Andrés, María-Luisa Gaspar, Javier García-Castro
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing. Cancer research communications 3 (3) (2023)
Álvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Stefano Gambera, Teresa Cejalvo, Belén de Andrés, María-Luisa Gaspar, Javier García-Castro
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing. Cancer research communications 3 (3) (2023)
Álvaro Morales-Molina, Stefano Gambera, Angela Leo, Javier García-Castro
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma. Journal for immunotherapy of cancer 9 (3) (2021)
Miguel Ángel Rodríguez-Milla, Álvaro Morales-Molina, Ana Judith Perisé-Barrios, Teresa Cejalvo, Javier García-Castro
AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses. Cancer gene therapy 28 (1-2) (2020)
Álvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Alicia Gimenez-Sanchez, Ana Judith Perisé-Barrios, Javier García-Castro
Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1+ Subsets in Mouse Immunocompetent Models. Cancers 12 (7) (2020)
Rafael Moreno, Carlos Alberto Fajardo, Martí Farrera-Sal, Ana Judith Perisé-Barrios, Álvaro Morales-Molina, Ahmed Abdullah Al-Zaher, Javier García-Castro, Ramon Alemany
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells. Molecular cancer therapeutics 18 (1) (2018)
Álvaro Morales-Molina, Stefano Gambera, Teresa Cejalvo, Rafael Moreno, Miguel Ángel Rodríguez-Milla, Ana Judith Perisé-Barrios, Javier García-Castro
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice. Cancer immunology, immunotherapy : CII 67 (10) (2018)